Dipeptidyl-Peptidase IV Inhibitors

Displaying 1 - 3 of 3CSV
Lin, T., Kang, E. Y., Shao, S., Lai, E. C., Wang, N., Garg, S. J., Chen, K., Kang, J., Wu, W., Lai, C., & Hwang, Y. (2024). Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan. Diabetes/Metabolism Research and Reviews, 40(2). Portico. https://doi.org/10.1002/dmrr.3773
Publication Date
Mahgoub, M. O., Ali, I. I., Adeghate, J. O., Tekes, K., Kalász, H., & Adeghate, E. A. (2023). An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 24(11), 9328. https://doi.org/10.3390/ijms24119328
Publication Date
Khera, R., Schuemie, M. J., Lu, Y., Ostropolets, A., Chen, R., Hripcsak, G., Ryan, P. B., Krumholz, H. M., & Suchard, M. A. (2022). Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open, 12(6), e057977. https://doi.org/10.1136/bmjopen-2021-057977
Publication Date